About this Research Topic
Cancer remains one of the deadliest diseases world-wide, accounting for around 600,000 deaths annually in the United States alone. In contrast to late-stage cancers, early-stage cancers or premalignant lesions are amenable to therapies with curative intent. Therefore, it is key to identify morphologic and physiologic changes associated with disease progression early-on. Current diagnostic standards for cancer surveillance and screening constitutes (contras-enhanced) CT, MRI, PET, ultrasound, and optical imaging, which are used for detection, staging and treatment planning.
The focus of this Topic is early diagnosis and treatment of cancers, and how to advance this objective. We welcome contributions from researchers with overlapping expertise in four thematic areas that include i) advancement of instrumentation, ii) refinement of molecular probes, iii) clinical evaluation of instruments and probes, and iv) image-guided therapies.
Keywords: cancer, early detection, guided resection, imaging, probe
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.